| Curious Chloride (CmCl3) and Titanic Chloride (TiCl4)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules for Cancer Treatment and Cellular … A Heidari Cancer Research and Cellular Therapeutics 2 (3), 10, 2018 | 56 | 2018 |
| The Impact of Sequencing Human Genome on the Genetically Engineered Life AH Khan Cancer Research and Cellular Therapeutics 6 (1), 16, 2022 | 9 | 2022 |
| Immunophenotyping Investigation in Acute and Chronic Leukemias as a Gold Standard Test AR Rahnemoon Cancer Research and Cellular Therapeutics 6 (1), 6, 2022 | 4 | 2022 |
| Calcitriol Revises Aromatase Gene Expression in Ehrlich Solid Tumor Bearing Mice Exposed to Low Dose Gamma Radiation GMAAAMF Nermeen M El Bakary, Khaled Sh Azab, Shaden M. Hanafy Cancer Research and Cellular Therapeutics 5 (1), 9, 2021 | 3* | 2021 |
| Complementary and Alternative Treatments for Cancer Prevention and Cure [Part 1] AK Mohiuddin Cancer Research and Cellular Therapeutics 3 (2), 54, 2019 | 3 | 2019 |
| The difference between targeted drug therapies and targeted-drug therapies K Petrak Cancer Research and Cellular Therapeutics 2 (4), 3, 2018 | 2 | 2018 |
| Wilson's Disease R Haider Cancer Research and Cellular Therapeutics 7 (3), 8, 2023 | 1 | 2023 |
| Pattern of Bacterial Infections in Cancer Patients -Experience from a Tertiary Cancer Center S Gupta Cancer Research and Cellular Therapeutics 6 (4), 4, 2022 | 1 | 2022 |
| Quality Assurance of Image Registration Using Combinatorial Rigid Registration Optimization (CORRO) TG Afua A. Yorke, Gary C. McDonald, David Solis Cancer Research and Cellular Therapeutics 5 (3), 9, 2021 | 1* | 2021 |
| Hepatitis B Virus-Associated Polyarteritis Nodosa: A Case Report HBVAPNAC Report Cancer Research and Cellular Therapeutics 8 (2), 4, 2024 | | 2024 |
| Identification of Symptoms and Factors Influencing Lung Cancer in Bangladeshi Adults KCB Atika F. Urmi, Mohammad A. Rahman Cancer Research and Cellular Therapeutics 8 (2), 6, 2024 | | 2024 |
| Weekly Carboplatin, Paclitaxel and Cetuximab with Pembrolizumab Every 3 Weeks Is Active and Tolerated in Patients with Locally Advanced and/or Metastatic/Recurrent Head and … RG Bruno CHAUFFERT, Marion GOGNARD, Abdenour OUIKENE, Mohamad CHEHIMI, Agnes ... Cancer Research and Cellular Therapeutics 8 (1), 4, 2024 | | 2024 |
| Cervical Cancer Prevention Paradox: Unveiling Screening Barriers and Solutions EIO Esther Ugo Alum, Okechukwu P. C. Ugwu Cancer Research and Cellular Therapeutics 8 (2), 5, 2024 | | 2024 |
| Beyond Conventional Therapies: Exploring Nutritional Interventions for Cervical Cancer Patients CNU Esther Ugo Alum, Okechukwu P. C. Ugwu, Emmanuel Ifeanyi Obeagu Cancer Research and Cellular Therapeutics 8 (1), 6, 2024 | | 2024 |
| CHAT GPT - An advanced tool for Cancer care SN Surbhi Tyagi Cancer Research and Cellular Therapeutics 8 (1), 3, 2024 | | 2024 |
| Current Status and Future Prospects of the Linear and Non-Linear Attenuation Coefficients of Cancer Cells, Tissues and Tumors by Synchrotron X-Ray Radiation (SXR) Computed … A Heidari Cancer Research and Cellular Therapeutics 7 (6), 8, 2023 | | 2023 |
| Immunotherapy: The Fourth Domain in Oral Cancer Therapeutics SC Ruby Dwivedi, Ayushi Jain, Shalini Gupta Cancer Research and Cellular Therapeutics 7 (6), 12, 2023 | | 2023 |
| The Status of Cancer and Reproductive Medicine and Sexual Health A Heidari Cancer Research and Cellular Therapeutics 7 (6), 8, 2023 | | 2023 |
| Molecular Progression and Multiple-Target Biomarkers in Multiple Myeloma: A Brief Review TK Amin Hasanpour Cancer Research and Cellular Therapeutics 7 (6), 5, 2023 | | 2023 |
| The work of the olfactory cell J Myjkowski Cancer Research and Cellular Therapeutics 7 (6), 4, 2023 | | 2023 |
